SC Pharmaceuticals: An investor briefing will be held on March 13 regarding the termination of the issuance of shares and cash payment for asset purchases, as well as the fundraising for supporting funds and related party transactions
SC Pharmaceuticals announced that the company will hold an investor briefing on March 13, 2025, from 15:00 to 16:00 on "Value Online" to communicate and exchange information with investors regarding the termination of the issuance of shares and cash payment for asset purchases, as well as the related fundraising and related party transactions. The company's chairman Wang Chengdong, vice president and board secretary Yu Xiaofeng, and others will attend the meeting. Investors can ask questions through the website or WeChat mini-program before the meeting